Artikel mit Open-Access-Mandaten - Ingo Schmidt-WolfWeitere Informationen
Nicht verfügbar: 4
Tumor-promoting versus tumor-antagonizing roles of γδ T cells in cancer immunotherapy: results from a prospective phase I/II trial
V Kunzmann, M Smetak, B Kimmel, K Weigang-Koehler, M Goebeler, ...
Journal of immunotherapy 35 (2), 205-213, 2012
Mandate: Deutsche Forschungsgemeinschaft
DNMT3A mutant transcript levels persist in remission and do not predict outcome in patients with acute myeloid leukemia
VI Gaidzik, D Weber, P Paschka, A Kaumanns, S Krieger, A Corbacioglu, ...
Leukemia 32 (1), 30-37, 2018
Mandate: Deutsche Forschungsgemeinschaft, Bundesministerium für Bildung und Forschung
Improving immunotherapy of hepatocellular carcinoma (HCC) using dendritic cells (DC) engineered to express IL‐12 in vivo
A Vogt, E Sievers, V Lukacs‐Kornek, G Decker, E Raskopf, N Meumann, ...
Liver International 34 (3), 447-461, 2014
Mandate: Deutsche Forschungsgemeinschaft
Epigenetic regulatory enzymes: mutation prevalence and coexistence in cancers
A Sharma, H Liu, MC Herwig-Carl, T Chand Dakal, IGH Schmidt-Wolf
Cancer Investigation 39 (3), 257-273, 2021
Mandate: Deutsche Forschungsgemeinschaft
Verfügbar: 29
Bortezomib before and after autologous stem cell transplantation overcomes the negative prognostic impact of renal impairment in newly diagnosed multiple myeloma: a subgroup …
C Scheid, P Sonneveld, IGH Schmidt-Wolf, B van der Holt, L el Jarari, ...
haematologica 99 (1), 148, 2014
Mandate: Dutch Cancer Society
Deregulated Expression of EVI1 Defines a Poor Prognostic Subset of MLL-Rearranged Acute Myeloid Leukemias: A Study of the German-Austrian Acute Myeloid …
S Groeschel, RF Schlenk, J Engelmann, V Rockova, V Teleanu, ...
Journal of clinical oncology 31 (1), 95-103, 2013
Mandate: Deutsche Forschungsgemeinschaft
Ethacrynic acid exhibits selective toxicity to chronic lymphocytic leukemia cells by inhibition of the Wnt/β-catenin pathway
D Lu, JX Liu, T Endo, H Zhou, S Yao, K Willert, IGH Schmidt-Wolf, ...
PloS one 4 (12), e8294, 2009
Mandate: US National Institutes of Health
Patient‐derived dendritic cells transduced with an a‐fetoprotein‐encoding adenovirus and co‐cultured with autologous cytokine‐induced lymphocytes induce a specific and strong …
MA González‐Carmona, A Märten, P Hoffmann, C Schneider, E Sievers, ...
Liver International 26 (3), 369-379, 2006
Mandate: Deutsche Forschungsgemeinschaft
Defective NKT cell activation by CD1d+ TRAMP prostate tumor cells is corrected by interleukin-12 with alpha-galactosylceramide
M Nowak, MS Arredouani, A Tun-Kyi, I Schmidt-Wolf, MG Sanda, SP Balk, ...
PloS one 5 (6), e11311, 2010
Mandate: US National Institutes of Health
CD40ligand‐expressing dendritic cells induce regression of hepatocellular carcinoma by activating innate and acquired immunity in vivo
MA Gonzalez‐Carmona, V Lukacs‐Kornek, A Timmerman, S Shabani, ...
Hepatology 48 (1), 157-168, 2008
Mandate: Deutsche Forschungsgemeinschaft
Activation of invariant NK T cells in periodontitis lesions
M Nowak, B Krämer, M Haupt, PN Papapanou, J Kebschull, P Hoffmann, ...
The Journal of Immunology 190 (5), 2282-2291, 2013
Mandate: US National Institutes of Health, Deutsche Forschungsgemeinschaft
Prognostic significance of cytogenetic heterogeneity in patients with newly diagnosed multiple myeloma
M Merz, A Jauch, T Hielscher, T Bochtler, SO Schönland, A Seckinger, ...
Blood advances 2 (1), 1-9, 2018
Mandate: Deutsche Forschungsgemeinschaft, Bundesministerium für Bildung und Forschung
Induction of cytotoxic effector cells towards cholangiocellular, pancreatic, and colorectal tumor cells by activation of the immune checkpoint CD40/CD40L on dendritic cells
F Sadeghlar, A Vogt, RU Mohr, R Mahn, K van Beekum, M Kornek, ...
Cancer Immunology, Immunotherapy 70, 1451-1464, 2021
Mandate: Deutsche Forschungsgemeinschaft
A recombinant anti-carcinoembryonic antigen immunoreceptor with combined CD3ζ-CD28 signalling targets T cells from colorectal cancer patients against their tumour cells
A Hombach, C Schlimper, E Sievers, S Frank, HH Schild, T Sauerbruch, ...
Gut 55 (8), 1156-1164, 2006
Mandate: Deutsche Forschungsgemeinschaft
Bortezomib induction and maintenance treatment improves survival in patients with newly diagnosed multiple myeloma: extended follow-up of the HOVON-65/GMMG-HD4 trial
P Sonneveld, C Scheid, B van der Holt, L el Jarari, U Bertsch, ...
Blood 122 (21), 404, 2013
Mandate: Dutch Cancer Society
Isolated central nervous system relapse of systemic lymphoma (SCNSL): clinical features and outcome of a retrospective analysis
K Patrij, M Reiser, L Wätzel, H Pels, A Kowoll, U Herrlinger, A Engert, ...
GMS German Medical Science 9, 2011
Mandate: US National Institutes of Health
Salvage therapy with high-dose cytarabine and mitoxantrone in combination with all-trans retinoic acid and gemtuzumab ozogamicin in acute myeloid leukemia refractory to first …
ML Huetter-Kroenke, A Benner, K Doehner, J Krauter, D Weber, ...
Haematologica 101 (7), 839, 2016
Mandate: Deutsche Forschungsgemeinschaft
Longitudinal fluorescence in situ hybridization reveals cytogenetic evolution in myeloma relapsing after autologous transplantation
M Merz, A Jauch, T Hielscher, EK Mai, A Seckinger, D Hose, U Bertsch, ...
haematologica 102 (8), 1432, 2017
Mandate: Deutsche Forschungsgemeinschaft, Bundesministerium für Bildung und Forschung
Alpha-fetoprotein-and CD40ligand-expressing dendritic cells for immunotherapy of hepatocellular carcinoma
A Vogt, F Sadeghlar, TH Ayub, C Schneider, C Möhring, T Zhou, R Mahn, ...
Cancers 13 (13), 3375, 2021
Mandate: Deutsche Forschungsgemeinschaft
EVs as potential new therapeutic tool/target in gastrointestinal cancer and HCC
A Słomka, T Mocan, B Wang, I Nenu, SK Urban, MA Gonzalez-Carmona, ...
Cancers 12 (10), 3019, 2020
Mandate: Deutsche Forschungsgemeinschaft
Angaben zur Publikation und Finanzierung werden automatisch von einem Computerprogramm ermittelt